NCC Launches Investigator-Led Studies on 5 Unapproved, Off-Label Drugs for Pediatric, AYA Cancers

January 22, 2024
Dr Ogawa (left) and NCC Hospital Director Kazuaki Shimada Meet the Press on Jan. 19 The National Cancer Center (NCC) said on January 19 that it has kicked off investigator-initiated studies earlier this month for six unapproved or off-label medicines...read more